Qingyi Lu

Dr. Qingyi Lu

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2006 in Nutrition and Cancer
Verified
Journal Article
Closed access
HLHua Lu
Hua Lu
LCLin Cai
Lin Cai
LMLi-Na Mu
Li-Na Mu
QLQingyi Lu
Qingyi Lu
JZJin kou Zhao
Jin kou Zhao
ZZZuo-Feng Zhang
Zuo-Feng Zhang
Few studies have been conducted in low-selenium areas of China to assess the relationships between dietary intake of selenium and zinc and the risk of squamous cell carcinoma of the esophagus (SCCE). We studied dietary mineral and trace element intake and risk of SCCE in a population- based, case-control study in Taixing, China, in 2000. A total of 218 SCCE patients and 415 population healthy controls were interviewed using a standard dietary and health questionnaire. The median and quartiles were calculated to represent the average level and distribution of selected dietary minerals and trace elements estimated by the Chinese Standard Tables of Food Composition. The adjusted odds ratios (ORs) comparing the highest with the lowest quartiles were 0.30 (95% confidence intervals, CIs = 0.13–0.67) for selenium intake and 0.28 (95% CI = 0.11–0.70) for zinc intake with obvious dose-dependent patterns (P values for trend = 0.01). The adjusted OR for the combined effect of selenium and zinc intake was 0...

1 November 2002 in Experimental Biology and Medicine
Verified
Journal Article
Open access
PDF file
DHDavid Heber
David Heber
QLQingyi Lu
Qingyi Lu
Dietary intakes of tomatoes and tomato products containing lycopene have been shown to be associated with decreased risk of chronic diseases such as cancer and cardiovascular diseases in numerous studies. Serum and tissue lycopene levels have also been inversely related to the risk of lung and prostate cancers. Lycopene functions as a very potent antioxidant, and this is clearly a major important mechanism of lycopene action. In this regard, lycopene can trap singlet oxygen and reduce mutagenesis in the Ames test. However, evidence is accumulating for other mechanisms as well. Lycopene at physiological concentrations can inhibit human cancer cell growth by interfering with growth factor receptor signaling and cell cycle progression specifically in prostate cancer cells without evidence of toxic effects or apoptosis of cells. Studies using human and animal cells have identified a gene, connexin 43, whose expression is upregulated by lycopene and which allows direct intercellular gap junctional communication (GJC). GJC is deficient in many human tumors and its restoration or upregulation is associated with decreased proliferation. The combination of low concentrations of lycopene with 1, 25-dihydroxyvitamin D3 exhibits a synergistic effect on cell proliferation and differentiation and an additive effect on cell cycle progression in the HL-60 promyelocyte leukemia cell line, suggesting some interaction at a nuclear or subcellular level. The combination of lycopene and lutein synergistically interact as antioxidants, and this may relate to specific positioning of different carotenoids in membranes. This review will focus on the growing body of evidence that carotenoids have unexpected biologic effects in experimental systems, some of which may contribute to their cancer preventive properties in models of carcinogenesis. Consideration of solubility In vitro, comparison with doses achieved in humans by dietary means, interactions with other phytochemicals, and other potential mechanisms such as stimulation of xenoblotic metabolism, inhibition of cholesterogenesis, modulation of cyclooxygenase pathways, and inhibition of inflammation will be considered. This review will point out areas for future research where more evidence is needed on the effects of lycopene on the etiology of chronic disease.

9 April 2001 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
VSVeronica Wendy Setiawan
Veronica Wendy Setiawan
ZZZuo-Feng Zhang
Zuo-Feng Zhang
GYGuo-Pei Yu
Guo-Pei Yu
QLQingyi Lu
Qingyi Lu
YLYong-Liang Li
Yong-Liang Li
CHChung-Cheng Hsieh
Chung-Cheng Hsieh
Despite the declining trend, stomach cancer remains the second most common cancer worldwide. We examined the role of green tea consumption on chronic gastritis and stomach cancer risks. A population‐based case‐control study was conducted in Yangzhong, China, with 133 stomach cancer cases, 166 chronic gastritis cases, and 433 healthy controls. Epidemiologic data were collected by standard questionnaire and odds ratios (OR) and 95% confidence intervals (CI) were estimated using logistic regression models in SAS. Inverse association was observed between green tea drinking and chronic gastritis and stomach cancer risks. After adjusting for age, gender, education, body mass index, pack‐years of smoking and alcohol drinking, ORs of green tea drinking were 0.52 (95% CI: 0.29–0.94) and 0.49 (95% CI: 0.31–0.77) for stomach cancer and chronic gastritis, respectively. In addition, dose‐response relationships were observed with years of green tea drinking in both diseases. The results provide further support on the protective effect of green tea against stomach cancer. This is the first time that green tea drinking was found to be protective against chronic gastritis, which may be of importance when designing intervention strategies for stomach cancer and its pre‐malignant lesions in the high‐risk population.

1 October 2005 in Molecular Cancer Therapeutics
Verified
Journal Article
Open access
PDF file
QZQunzhou Zhang
Qunzhou Zhang
XTXudong Tang
Xudong Tang
QLQingyi Lu
Qingyi Lu
ZZZuo-Feng Zhang
Zuo-Feng Zhang
JBJimmy Brown
Jimmy Brown
ALAnh D. Le
Anh D. Le
Hypoxia-inducible factor-1α (HIF-1α) is overexpressed in many human tumors and their metastases, and is closely associated with a more aggressive tumor phenotype. In this study, we investigated the effect of resveratrol, a natural product commonly found in grapes and various other fruits, on hypoxia-induced HIF-1α protein accumulation and vascular endothelial growth factor (VEGF) expression in human tongue squamous cell carcinomas and hepatoma cells. Our results showed that resveratrol significantly inhibited both basal level and hypoxia-induced HIF-1α protein accumulation in cancer cells, but did not affect HIF-1α mRNA levels. Pretreatment of cells with resveratrol significantly reduced hypoxia-induced VEGF promoter activities and VEGF expression at both mRNA and protein levels. The mechanism of resveratrol inhibition of hypoxia-induced HIF-1α accumulation seems to involve a gradually shortened half-life of HIF-1α protein caused by an enhanced protein degradation through the 26S proteasome system. In addition, resveratrol remarkably inhibited hypoxia-mediated activation of extracellular signal-regulated kinase 1/2 and Akt, leading to a marked decrease in hypoxia-induced HIF-1α protein accumulation and VEGF transcriptional activation. Functionally, we observed that resveratrol also significantly inhibited the hypoxia-stimulated invasiveness of cancer cells. These data suggested that HIF-1α/VEGF could be a promising drug target for resveratrol in the development of an effective chemopreventive and anticancer therapy in human cancers.

1 January 2005 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
QLQingyi Lu
Qingyi Lu
JAJames R. Arteaga
James R. Arteaga
QZQifeng Zhang
Qifeng Zhang
VA North Texas Health Care SystemVA North Texas Health Care System
VA North Texas Health Care System
VGVay Liang W. Go
Vay Liang W. Go
DHDavid Heber
David Heber

1 May 2006 in Molecular Cancer Therapeutics
Verified
Journal Article
Open access
PDF file
QZQunzhou Zhang
Qunzhou Zhang
XTXudong Tang
Xudong Tang
QLQingyi Lu
Qingyi Lu
ZZZuo-Feng Zhang
Zuo-Feng Zhang
JRJianyu Rao
Jianyu Rao
ALAnh D. Le
Anh D. Le
Green tea extract and its major component (−)-epigallocatechin-3-gallate (EGCG) exhibit antiangiogenic activities in various experimental tumor models. A growing body of evidence has established that hypoxia-inducible factor-1α (HIF-1α) and its downstream target, vascular endothelial growth factor (VEGF), play a critical role in tumor angiogenesis. In this study, we investigated the effect of green tea extract and EGCG on HIF-1α and VEGF expression in human cervical carcinoma (HeLa) and hepatoma (HepG2) cells. Our results showed that green tea extract and EGCG significantly inhibited hypoxia- and serum-induced HIF-1α protein accumulation in these cancer cells but had no effects on HIF-1α mRNA expression. Suppression of HIF-1α protein by green tea extract and EGCG also resulted in a drastic decrease in VEGF expression at both mRNA and protein levels. The mechanisms of green tea extract and EGCG inhibition of hypoxia-induced HIF-1α protein accumulation seem to involve the blocking of both phosphatidylinositol 3-kinase/Akt and extracellular signal-regulated kinase 1/2 signaling pathways and the enhancing of HIF-1α protein degradation through the proteasome system. In addition, green tea extract and EGCG inhibited serum-induced HIF-1α protein and VEGF expression by interfering with the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathways, which play a crucial role in the protein translational machinery cascade. Functionally, green tea extract and EGCG abolished both chemoattractant- and hypoxia-stimulated HeLa cell migration. Our data suggested that HIF-1α/VEGF function as therapeutic target for green tea extract and EGCG in the context of cancer chemoprevention and anticancer therapy. [Mol Cancer Ther 2006;5(5):1227–38]